Cover Image
市場調查報告書

萎縮:全球臨床實驗檢討

Atrophy Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 296481
出版日期 內容資訊 英文 108 Pages
訂單完成後即時交付
價格
Back to Top
萎縮:全球臨床實驗檢討 Atrophy Global Clinical Trials Review, H1, 2014
出版日期: 2014年02月19日 內容資訊: 英文 108 Pages
簡介

所謂萎縮是指瘦下縮小。有肌肉萎縮、陰道萎縮、視神經萎縮、脊髓性肌肉萎縮等許多種類。

本報告提供萎縮的治療藥相關臨床實驗調查分析,提供臨床實驗數及被實驗人數,各階段及各方面狀況,有潛力的企業,正在開發的治療藥的資訊,臨床實驗簡介等,為您概述為以下內容。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗趨勢
    • 亞太地區的主要國家
    • 歐洲的主要國家
    • 北美的主要國家
    • 中東·非洲的主要國家
    • 中·南美的主要國家

G7各國的臨床實驗:皮膚科臨床實驗中萎縮的比例

G7各國的臨床實驗:各階段

G7各國的臨床實驗:各階段

E7各國的臨床實驗:皮膚科臨床實驗中萎縮的比例

E7各國的臨床實驗:各階段

E7各國的臨床實驗:各階段

各方面的臨床實驗

各階段臨床實驗

評估項目別臨床實驗

未完成的臨床實驗

一定期間所採用的實驗對象

贊助商各類型臨床實驗

有潛力的贊助商

  • 參與萎縮的治療藥臨床實驗的主要企業

有前途藥物

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Othera Pharmaceuticals, Inc.
    • Novartis AG
    • Karo Bio AB
    • GlaxoSmithKline plc
    • SBI Biotech Co., Ltd.
    • Laboratoires Pierre Fabre SA
    • Juvantia Pharma Oy
    • Chelsea Therapeutics International Ltd.
    • Biogen Idec Inc.
    • AstraZeneca PLC
  • 主要大學·研究機關·醫院臨床實驗概要
    • Vanderbilt University
    • Maastricht University Medical Center
    • National Eye Institute
    • University Hospital, Toulouse
    • University of Sao Paulo
    • Federal University of Sao Paulo
    • National Institute of Neurological Disorders and Stroke
    • University of Massachusetts
    • Glostrup University Hospital
    • University Hospital, Bordeaux

主要的臨床簡介

附錄

圖表

目錄
Product Code: GDHC1975CTIDB

GlobalData's clinical trial report, "Atrophy Global Clinical Trials Review, H1, 2014" provides data on the Atrophy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Atrophy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Atrophy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Atrophy
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Atrophy to Dermatology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Atrophy to Dermatology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Atrophy
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Atrophy Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Othera Pharmaceuticals, Inc.
      • Clinical Trial Overview of Othera Pharmaceuticals, Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Karo Bio AB
      • Clinical Trial Overview of Karo Bio AB
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • SBI Biotech Co., Ltd.
      • Clinical Trial Overview of SBI Biotech Co., Ltd.
      • Laboratoires Pierre Fabre SA
      • Clinical Trial Overview of Laboratoires Pierre Fabre SA
      • Juvantia Pharma Oy
      • Clinical Trial Overview of Juvantia Pharma Oy
      • Chelsea Therapeutics International Ltd.
      • Clinical Trial Overview of Chelsea Therapeutics International Ltd.
      • Biogen Idec Inc.
      • Clinical Trial Overview of Biogen Idec Inc.
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
    • Clinical Trial Overview of Top Institutes / Government
      • Vanderbilt University
      • Clinical Trial Overview of Vanderbilt University
      • Maastricht University Medical Center
      • Clinical Trial Overview of Maastricht University Medical Center
      • National Eye Institute
      • Clinical Trial Overview of National Eye Institute
      • University Hospital, Toulouse
      • Clinical Trial Overview of University Hospital, Toulouse
      • University of Sao Paulo
      • Clinical Trial Overview of University of Sao Paulo
      • Federal University of Sao Paulo
      • Clinical Trial Overview of Federal University of Sao Paulo
      • National Institute of Neurological Disorders and Stroke
      • Clinical Trial Overview of National Institute of Neurological Disorders and Stroke
      • University of Massachusetts
      • Clinical Trial Overview of University of Massachusetts
      • Glostrup University Hospital
      • Clinical Trial Overview of Glostrup University Hospital
      • University Hospital, Bordeaux
      • Clinical Trial Overview of University Hospital, Bordeaux
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Atrophy Therapeutics, Global, Clinical Trials by Region, 2014*
  • Atrophy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Atrophy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Atrophy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Atrophy Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Atrophy Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Atrophy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Atrophy Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Atrophy to Dermatology Clinical Trials, G7 Countries (%), 2014*
  • Atrophy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Atrophy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Atrophy to Dermatology Clinical Trials, E7 Countries (%), 2014*
  • Atrophy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Atrophy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Atrophy Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Atrophy Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Atrophy Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Atrophy Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Atrophy Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Atrophy Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Atrophy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Atrophy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Atrophy Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Atrophy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Atrophy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Othera Pharmaceuticals, Inc., 2014*
  • Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Karo Bio AB, 2014*
  • Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by SBI Biotech Co., Ltd., 2014*
  • Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires Pierre Fabre SA, 2014*
  • Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Juvantia Pharma Oy, 2014*
  • Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Chelsea Therapeutics International Ltd., 2014*
  • Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2014*
  • Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2014*
  • Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2014*
  • Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2014*
  • Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Toulouse, 2014*
  • Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2014*
  • Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2014*
  • Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014*
  • Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Massachusetts, 2014*
  • Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Glostrup University Hospital, 2014*
  • Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Bordeaux, 2014*

List of Figures

  • Atrophy Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Atrophy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Atrophy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Atrophy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Atrophy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Atrophy Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Atrophy Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Atrophy Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Atrophy to Dermatology Clinical Trials, G7 Countries (%), 2014*
  • Atrophy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Atrophy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Atrophy to Dermatology Clinical Trials, E7 Countries (%), 2014*
  • Atrophy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Atrophy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Atrophy Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Atrophy Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Atrophy Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Atrophy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Atrophy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Atrophy Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Atrophy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Atrophy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top